- Home
- CNTA vs AVNT Comparison
CNTA vs AVNT Comparison
Compare CNTA & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | AVNT |
|---|---|---|
| Founded | 2020 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.4B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CNTA | AVNT |
|---|---|---|
| Price | $39.64 | $38.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $42.00 | $41.50 |
| AVG Volume (30 Days) | ★ 4.2M | 721.2K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ 0.89 |
| Revenue | $15,000,000.00 | ★ $3,835,500,000.00 |
| Revenue This Year | N/A | $4.90 |
| Revenue Next Year | N/A | $3.48 |
| P/E Ratio | ★ N/A | $42.08 |
| Revenue Growth | N/A | ★ 1.71 |
| 52 Week Low | $10.95 | $27.48 |
| 52 Week High | $40.26 | $44.85 |
Technical Indicators
Market Signals| Indicator | CNTA | AVNT |
|---|---|---|
| Relative Strength Index (RSI) | 76.90 | 60.74 |
| Support Level | $24.80 | $30.58 |
| Resistance Level | $40.26 | $44.85 |
| Average True Range (ATR) | 1.07 | 1.13 |
| MACD | 0.80 | 0.48 |
| Stochastic Oscillator | 96.49 | 99.73 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.